期刊
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
卷 302, 期 15, 页码 1685-1692出版社
AMER MEDICAL ASSOC
DOI: 10.1001/jama.2009.1498
关键词
-
资金
- [U01CA111234]
- [U01CA086402]
After 20 years of screening for breast and prostate cancer, several observations can be made. First, the incidence of these cancers increased after the introduction of screening but has never returned to prescreening levels. Second, the increase in the relative fraction of early stage cancers has increased. Third, the incidence of regional cancers has not decreased at a commensurate rate. One possible explanation is that screening may be increasing the burden of low-risk cancers without significantly reducing the burden of more aggressively growing cancers and therefore not resulting in the anticipated reduction in cancer mortality. To reduce morbidity and mortality from prostate cancer and breast cancer, new approaches for screening, early detection, and prevention for both diseases should be considered. JAMA. 2009;302(15):1685-1692
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据